APMA presented oral testimony to HHS' Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) on June 5, requesting that APMA and CPME be approved as a provider and accrediting entity, respectively, for the new DEA MATE Act requirements.
Effective July 1, providers and suppliers are required to report the JZ modifier on all claims that bill for drugs and biologicals from single-dose containers that are separately payable under Medicare Part B when there are no discarded amounts.
Registration for the 2023 State Advocacy Forum will open soon! We ask that all state components and societies share the application provided here with their young physician members and encourage them to apply by the May 31 deadline.
Last week, APMA submitted formal comments to the Substance Abuse and Mental Health Services Administration (SAMHSA), expressing our ongoing concerns related to the DEA MATE Act, and following up our meeting on April 28.
APMA joined with AMA and other specialty medical societies to submit a comment letter regarding Cigna’s modifier 25 policy.
The implementation date for the revised fellowship documents, CPME 820 and 830, is July 1.
APMA is pleased and proud to announce that the Alabama Podiatric Medical Association (ALPMA) has succeeded in its long-term efforts to modernize the Alabama scope of practice statute. Alabama Governor Kay Ivey (R) signed Senate Bill 28 into law on May 3, updating podiatrists’ scope to include the ankle. The bill will take effect August 1.
The DEA recently released a temporary rule extending COVID-19 telehealth flexibilities for the prescription of controlled substances.
The APMA Coding Committee and Health Policy and Practice Committee held meetings last week to discuss ongoing concerns and plan member education for the upcoming year.
You can now submit your 2023 Performance Year MIPS Extreme and Uncontrollable Circumstances (EUC) Exception application!
APMA welcomes inquiries from the media! The Media Room provides journalists with information on podiatric medicine, educational campaigns, and national surveys related to podiatry and foot health. More information and fact sheets can also be found in our Patients & the Public section.
Please reach out to APMA Communications and Marketing Director Peggy S. Tresky, MA, (phone 301-581-9200) for questions or interview requests.
Foot and ankle physicians and surgeons witness parallel public health crisis as pandemic continues
APMA is partnering with NextGen Healthcare, Inc., and Darena Solutions to provide expanded options for MIPS reporting and data analytics to podiatrists. The partnership enables the exchange of crucial patient data, simplifies MIPS reporting, and provides APMA with data to advocate on behalf of members.
After the passage of the VA Provider Equity Act in the 115th Congress resolved podiatrist-access issues in the Veterans Health Administration, APMA is hopeful Congress will take long overdue action to address these issues for Medicaid patients.
David G. Edwards, DPM, of Logan, UT, was installed as president of the American Podiatric Medical Association (APMA) during the organization’s 99th House of Delegates meeting in March.
Today’s Podiatrist is your highly trained foot and ankle surgical expert.
* indicates a required field